🚀 VC round data is live in beta, check it out!

APT Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for APT Medical and similar public comparables like Snibe, Ypsomed, Andon Health, Imeik Technology Development and more.

APT Medical Overview

About APT Medical

APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.


Founded

2002

HQ

China

Employees

N/A

Website

aptmed.com

Financials (LTM)

Revenue: $406M
EBITDA: $161M

EV

$5B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

APT Medical Financials

APT Medical reported last 12-month revenue of $406M and EBITDA of $161M.

In the same LTM period, APT Medical generated $296M in gross profit, $161M in EBITDA, and $129M in net income.

Revenue (LTM)


APT Medical P&L

In the most recent fiscal year, APT Medical reported revenue of $379M and EBITDA of $154M.

APT Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See APT Medical forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$406MXXX$379MXXXXXXXXX
Gross Profit$296MXXX$276MXXXXXXXXX
Gross Margin73%XXX73%XXXXXXXXX
EBITDA$161MXXX$154MXXXXXXXXX
EBITDA Margin40%XXX41%XXXXXXXXX
EBIT Margin36%XXX37%XXXXXXXXX
Net Profit$129MXXX$120MXXXXXXXXX
Net Margin32%XXX32%XXXXXXXXX

Financial data powered by Morningstar, Inc.

APT Medical Stock Performance

APT Medical has current market cap of $5B, and enterprise value of $5B.

Market Cap Evolution


APT Medical's stock price is $37.53.

See APT Medical trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$5B0.0%XXXXXXXXX$0.85

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

APT Medical Valuation Multiples

APT Medical trades at 12.5x EV/Revenue multiple, and 31.4x EV/EBITDA.

See valuation multiples for APT Medical and 15K+ public comps

EV / Revenue (LTM)


APT Medical Financial Valuation Multiples

As of April 20, 2026, APT Medical has market cap of $5B and EV of $5B.

Equity research analysts estimate APT Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

APT Medical has a P/E ratio of 41.1x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$5BXXX$5BXXXXXXXXX
EV (current)$5BXXX$5BXXXXXXXXX
EV/Revenue12.5xXXX13.4xXXXXXXXXX
EV/EBITDA31.4xXXX33.0xXXXXXXXXX
EV/EBIT34.7xXXX36.6xXXXXXXXXX
EV/Gross Profit17.1xXXX18.4xXXXXXXXXX
P/E41.1xXXX44.0xXXXXXXXXX
EV/FCF53.8xXXX50.7xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified APT Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

APT Medical Margins & Growth Rates

APT Medical's revenue in the last 12 month grew by 27%.

APT Medical's rule of 40 is 66% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

APT Medical's rule of X is 106% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for APT Medical and other 15K+ public comps

APT Medical Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth27%XXX26%XXXXXXXXX
EBITDA Margin40%XXX41%XXXXXXXXX
EBITDA Growth27%XXX24%XXXXXXXXX
Rule of 40—XXX66%XXXXXXXXX
Bessemer Rule of X—XXX106%XXXXXXXXX
S&M Expenses to Revenue18%XXX18%XXXXXXXXX
G&A Expenses to Revenue5%XXX5%XXXXXXXXX
R&D Expenses to Revenue14%XXX14%XXXXXXXXX
Opex to Revenue—XXX36%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

APT Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
APT MedicalXXXXXXXXXXXXXXXXXX
SnibeXXXXXXXXXXXXXXXXXX
YpsomedXXXXXXXXXXXXXXXXXX
Andon HealthXXXXXXXXXXXXXXXXXX
Imeik Technology DevelopmentXXXXXXXXXXXXXXXXXX
HoribaXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

APT Medical M&A Activity

APT Medical acquired XXX companies to date.

Last acquisition by APT Medical was on XXXXXXXX, XXXXX. APT Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by APT Medical

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

APT Medical Investment Activity

APT Medical invested in XXX companies to date.

APT Medical made its latest investment on XXXXXXXX, XXXXX. APT Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by APT Medical

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About APT Medical

When was APT Medical founded?APT Medical was founded in 2002.
Where is APT Medical headquartered?APT Medical is headquartered in China.
Is APT Medical publicly listed?Yes, APT Medical is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of APT Medical?APT Medical trades under 688617 ticker.
When did APT Medical go public?APT Medical went public in 2021.
Who are competitors of APT Medical?APT Medical main competitors are Snibe, Ypsomed, Andon Health, Imeik Technology Development.
What is the current market cap of APT Medical?APT Medical's current market cap is $5B.
What is the current revenue of APT Medical?APT Medical's last 12 months revenue is $406M.
What is the current revenue growth of APT Medical?APT Medical revenue growth (NTM/LTM) is 27%.
What is the current EV/Revenue multiple of APT Medical?Current revenue multiple of APT Medical is 12.5x.
Is APT Medical profitable?Yes, APT Medical is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of APT Medical?APT Medical's last 12 months EBITDA is $161M.
What is APT Medical's EBITDA margin?APT Medical's last 12 months EBITDA margin is 40%.
What is the current EV/EBITDA multiple of APT Medical?Current EBITDA multiple of APT Medical is 31.4x.
What is the current FCF of APT Medical?APT Medical's last 12 months FCF is $94M.
What is APT Medical's FCF margin?APT Medical's last 12 months FCF margin is 23%.
What is the current EV/FCF multiple of APT Medical?Current FCF multiple of APT Medical is 53.8x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial